PercepTx specializes in preclinical optimization for biologics drug development. We combine our deep understanding of IND-enabling biologics development and model-based screening to help rigorously evaluate and accelerate preclinical pipelines in cancer biologics. PercepTx empowers companies to focus their resources on the critical activities that increase the likelihood of success, while lowering overall costs.

We offer a unique and thorough means to understand and maximize the therapeutic index of your asset, using the right combination of stream-lined preclinical studies, quantitative pharmacology modeling, and proprietary analytical tools. Our targeted approach to applied modeling can be utilized for translational modeling, quantitative systems pharmacology, indication selection, preclinical optimization and combination strategic guidance.

Our work with you will produce actionable insights that will allow your team to design a more effective drug and create a clinical strategy with significantly higher likelihood of success.